Organon (OGN) Debt to Equity (2020 - 2026)

Organon (OGN) posted quarterly Debt to Equity of $9.49 for Q1 2026, down 42.57% year-over-year from $16.52 in Q1 2025, and down 17.44% on a QoQ basis from $11.49 in Q4 2025.

Organon (OGN) Debt to Equity (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Debt to Equity for 7 consecutive years, with $9.49 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt to Equity fell 42.57% year-over-year to $9.49; the TTM figure through Mar 2026 stood at $9.49 (down 42.57% YoY), while the FY2025 annual figure was $11.49, down 38.9% from the prior year.
  • Debt to Equity came in at $9.49 for Q1 2026 at Organon, down from $11.49 in the prior quarter.
  • The five-year high for Debt to Equity was $181.54 in Q1 2024, with the low at -$125.14 in Q4 2023.
  • Average Debt to Equity over 5 years is $8.06, with a median of $9.49 recorded in 2026.
  • Across the five-year window, Debt to Equity slumped 2360.1% in 2022 and surged 1635.95% in 2024, its largest moves.
  • Year by year, Debt to Equity stood at -$9.99 in 2022, then tumbled by 1152.41% to -$125.14 in 2023, then surged by 115.03% to $18.81 in 2024, then sank by 38.9% to $11.49 in 2025, then slipped by 17.44% to $9.49 in 2026.
  • According to Business Quant data, Debt to Equity over the past three periods registered $9.49, $11.49, and $9.74 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 1.39
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 0.68
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -9.70
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 1.07
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 6.24
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 0.94
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 0.72
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 9.49

Historic Data

Download Data
DateValue
Mar 31, 2026 9.49
Dec 31, 2025 11.49
Sep 30, 2025 9.74
Jun 30, 2025 12.14
Mar 31, 2025 16.52
Dec 31, 2024 18.81
Sep 30, 2024 17.75
Jun 30, 2024 60.11
Mar 31, 2024 181.54
Dec 31, 2023 -125.14
Sep 30, 2023 -14.69
Jun 30, 2023 -15.73
Mar 31, 2023 -11.82
Dec 31, 2022 -9.99
Sep 30, 2022 -8.16
Jun 30, 2022 -7.82
Mar 31, 2022 -7.28
Dec 31, 2021 -6.06
Sep 30, 2021 -5.75
Jun 30, 2021 -4.81